Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brigitte C Widemann, M.D.
National Cancer Institute, National Institutes of Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Childrens National Medical Center
Washington D.C., District of Columbia, United States
- Childrens Memorial Hospital, Chicago
Chicago, Illinois, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
- Childrens Hospital, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic, Rochester
Rochester, Minnesota, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- Beth Israel Medical Center
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- Childrens Hospital, Philadelphia
Philadelphia, Pennsylvania, United States
- Childrens Hospital, Pittsburgh
Pittsburgh, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jul 2004
- Primary completion
- 1 Apr 2010
- Completion
- 1 Apr 2010
- Last update posted
- 23 Apr 2018
- Registered enrollment
- 36
- Registry id
- NCT00076102
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.